buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217
Published March 6, 2013 · Recall initiated: January 4, 2013
Summary
FDA records drug Class III recall D-175-2013, published March 6, 2013 and initiated January 4, 2013. Recalling firm: Actavis Pharmaceuticals; Status: Terminated; Reported quantity: 14,856 bottles; Lot: Lot CB1D05A,. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Actavis Pharmaceuticals
- Distributor
- Nationwide
- Lot
- Lot CB1D05A,
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIsoniazid Tablets 300 mg tablets USP, Rx Only, a) 30 tablets - NDC 61748-013-30, b) 100 tablets - NDCMarch 6, 2013
- FDA0.9% Sodium Chloride Irrigation, USP, 3000 mL, Sterile, Non pyrogenic, Rx Only, Hospira, Inc., Lake Forest, ILMarch 6, 2013
- FDADextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by CatalentMarch 6, 2013
- FDABronkaid Dual Action Formula, Ephedrine Sulfate 25 mg/Bronchodilator, Guaifenesin 400 mg/Expectorant, a) 24March 6, 2013
- FDADextroamphetamine Sulfate Extended Release Capsules, 5 mg, 90 capsules, Rx only, Manufactured by CatalentMarch 6, 2013
- FDACitalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited,March 6, 2013
Questions about this recall
Was buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217 recalled?
Yes. FDA published recall D-175-2013 on March 6, 2013. Reported hazard: Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.
What should I do if I have this product?
Voluntary: Firm initiated · Letter